Background: Many women use contraception, and many of them spend a substantial portion of their lives attempting to postpone or prepare for pregnancy. As a result, the current study sought to assess numerous parameters associated with Sudanese women's use of contraceptive pills. Methodology: This descriptive study took place in Khartoum, Sudan from March to September 2022. The study comprised 100 women of reproductive age. All study participants were current or former users of hormonal contraceptive pills. Results: 30% of users claimed to have used it without a prescription, while 70% said they had taken it as the doctor had instructed. The majority of participants (57%) took the pills for more than one year, followed by a period of one to twelve months. 41% of the study participants used the pills consistently, whereas the remaining 59% used them infrequently. About 80% of those who said they were aware of the side effects of the pills said they would appear between one month and a year after taking them, with 33% saying they would do so within a month. Conclusion: Hormonal contraceptives (HCs) are routinely used without a doctor's prescription in Sudan. The great majority of HCs users report negative effects that could be attributed to incorrect use. Efforts are needed to raise the awareness of Sudanese women about the importance of the proper use of contraceptive pills.
Background: The side effects of hormonal contraceptives (HCs) vary greatly between women, and different HCs cause distinct side effects. This study aimed to assess the rife of self-confessed disorders associated with hormonal contraceptives. Methodology: The study enrolled 200 ladies of reproductive age. One hundred women were HCs users (ascertained as cases) and 100 women non-contraceptives users (ascertained as a control group). Results: Irregular menstrual cycles were observed in 29% of the cases and 28% of the controls. In 21% of cases, the duration of menstruation recycling was unpredictable, compared to 26% in controls. Hormonal abnormalities were more common among controls than among cases. The hormonal associated problems in controls were: OR (95%CI) = 2.5550(1.1753 to 5.5545), P-value = 0.0179. The risk of recurrent infection among control group was OR (95%CI) = 1.5952 (0.8984 to 2.8326), P = 0.1109. Conclusion: The current study revealed no statistically significant differences in hormonal contraceptive-related illnesses between HCs users and non-users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.